Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2004
11/24/2004CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them
11/24/2004CN1549714A Aminoisoxazole derivatives active as kinase inhibitors
11/24/2004CN1549713A Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof
11/24/2004CN1549705A Extended release oral dosage form
11/24/2004CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004CN1548434A Benzothiophene compounds and their prepn and medicine use
11/24/2004CN1548432A Stabilizing method and medicine composition of catechin monomer
11/24/2004CN1548421A Tilmisartan salt and its prepn
11/24/2004CN1548130A Medicine for treating coronary heart disease and angina pectoris and its pharmacologic effect
11/24/2004CN1548119A Yiqingwan bolus and its prepn
11/24/2004CN1548077A Chinese medicine prepn for treating coronary heart disease and rheumatic heart disease
11/24/2004CN1548076A Liquid composition prepn of magnesium salt and blood circulation promoting and blood clots dispersing Chinese medicine
11/24/2004CN1548061A Mongolia medicine for treating coronary heart disease and angina pectoris
11/24/2004CN1548058A Prepn process of alive adult roach extract
11/24/2004CN1548047A Cyclovirobuxine dripping pill and its prepn. process
11/24/2004CN1548046A Baicalin-zinc medicine
11/24/2004CN1548039A Red sage dripping pill and its prepn
11/24/2004CN1177039C Bacillus adhaerens and its use in preparing health food having thrombolysis property
11/24/2004CN1176941C Caspase inhibitors and the use thereof
11/24/2004CN1176932C Zinc fructose-diphosphate and its preparing process and application
11/24/2004CN1176922C 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors
11/24/2004CN1176916C Semi-synthetic taxanes with antitumor and antiangiogenetic activities
11/24/2004CN1176911C Benzidine-sulfuryl radical substitution pentatomic heterocycle, its preparation method, its medicinal and composition
11/24/2004CN1176909C Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same
11/24/2004CN1176903C Method for synthesis of N-[(S)-1-carboxybutyl]-(S)-alanine esters and use in synthesis of perindoprill
11/24/2004CN1176716C Composition for prevention and/or treatment of atheromatous arteriosclerosis
11/24/2004CN1176711C Dampness-removing embolism-dissolving medicinal liquor
11/24/2004CN1176709C Drug for curing scald, wound as well as hemorrhoids
11/24/2004CN1176707C Guttate pills for treating obstruction of qi in the chest and chest pain and preparing process thereof
11/24/2004CN1176696C Process for preparing Chinese medicine for treating hyperlipemia, hypertension and arteriosclerosis
11/24/2004CN1176685C Medicine for preventing and treating coronary heart disease and its prepn process
11/24/2004CN1176677C Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and its preparing process
11/24/2004CN1176674C Rehmannia root extract and its preparing process and application
11/24/2004CN1176670C Active animal protein liquid and its application
11/24/2004CN1176660C Pharmaceutical application of froctose biphosphate magnesium
11/24/2004CN1176658C Aseptic freeze-dried prostaglandin injection and its preparing method and use
11/24/2004CN1176656C Freeze-drying composition for injection
11/24/2004CN1176648C Hawthorn leaves total flavone soft capsule and its preparing method
11/23/2004US6822141 Diacylglycerol acyl transferase proteins
11/23/2004US6822120 Sulfone liver X-receptor modulators
11/23/2004US6822112 Prostaglandin derivatives
11/23/2004US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders
11/23/2004US6822099 Method of resolving amlodipine racemate
11/23/2004US6822097 Compounds and methods of uses
11/23/2004US6821987 4-substituted by azolylureido-phenoxy, or phenylthio; antitumor agents; treating diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis,
11/23/2004US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004US6821985 Administering an nr2b subtype selective n-methyl-d-aspartate (nmda) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke
11/23/2004US6821984 Ring fused pyrazole derivatives as CRF antagonists
11/23/2004US6821978 Xanthine phosphodiesterase V inhibitors
11/23/2004US6821977 Antidiabetic agents
11/23/2004US6821974 Vasodilation; hypotensive agents; cardiovascular disorders
11/23/2004US6821973 Compounds
11/23/2004US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia
11/23/2004US6821970 Useful for treating diseases wherein modulation of 5-ht activity is desired; nervous system disorders
11/23/2004US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/23/2004US6821966 Antiinflammatory agents
11/23/2004US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004US6821964 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation
11/23/2004US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases
11/23/2004US6821956 Oligodeoxynucleotide decoys for the prophylactic or therapeutic treatment of diseases associated with the binding of endogenous transcription factors to genes involved in cell growth, differentiation and signalling or to viral genes.
11/23/2004US6821950 Antagonist of a g protein-coupled receptor, which has no agonist activity, and which has a cyclic or constrained acyclic structure
11/23/2004US6821394 Process of extracting from haw-pit by dry distillation and its device
11/23/2004CA2329788C Quinoline derivatives
11/23/2004CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004CA2161346C Sulfonamides and derivatives thereof that modulate the activity of endothelin
11/23/2004CA2135768C Indolocarbazole imides and the use thereof
11/23/2004CA2125288C Serotoninergic ergoline derivatives
11/23/2004CA2111662C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
11/18/2004WO2004099394A2 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system
11/18/2004WO2004099180A1 Novel piperidine derivatives
11/18/2004WO2004099179A1 Piperazine-alkyl-ureido derivatives
11/18/2004WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004WO2004099137A1 Aminocyclohexyl ether compounds and uses thereof
11/18/2004WO2004099133A1 2”-hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food
11/18/2004WO2004098713A2 Treating cardiovascular diseases with a compound of formula (i) (cs 747 - prasugrel; rn 150322-43-4)
11/18/2004WO2004098638A1 Effector cell function inhibitor
11/18/2004WO2004098634A2 Protein arginine n-methyltransferase 2 (prmt-2)
11/18/2004WO2004098623A1 A notoginseng saponin intravenous injection and the method for preparing this injection
11/18/2004WO2004098611A1 Fortifier
11/18/2004WO2004098604A1 Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use
11/18/2004WO2004098525A2 Uses of ion channel modulating compounds
11/18/2004WO2004098499A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
11/18/2004WO2004082582A3 Use of diazoxide in the treatment of ischemia retinae
11/18/2004WO2004082573A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
11/18/2004WO2004073613A3 A medicine and food
11/18/2004WO2004073593A3 Use of acylated aminopropanediols and sulphur and nitrogen analogues of same for different therapeutic applications
11/18/2004WO2004071381A3 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
11/18/2004WO2004062686A3 Therapeutic use of modulators of notch
11/18/2004WO2004038406A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42)
11/18/2004WO2004002528A9 Compositions and methods for therapeutic treatment
11/18/2004WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004WO2002086087A3 Cytokine protein family
11/18/2004US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
11/18/2004US20040230064 Novel labeled resiniferatoxin derivatives
11/18/2004US20040229957 cholesterol ester transfer protein inhibitors, new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia
11/18/2004US20040229946 Antidiabetic agents
11/18/2004US20040229945 use in inhibiting angiogenesis in a mammal
11/18/2004US20040229933 Treatment of hypertension